Tokyo, March 24 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061023) titled 'The effcts of antacid administration on phosphate binders in patients undergoing dialysis' on March 24.
Study Type:
Observational
Primary Sponsor:
Institute - Patient Driven Academic League
Condition:
Condition - hronic renal failure undergoing dialysis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - In this study, using the MBD-NEXT database, a high-granularity real-world data set of Japanese hemodialysis patients, we aim to elucidate the impact of proton pump inhibitor use on the prescription volume of phosphate binders in maintenance hemodialysis patients.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Hemodialysis patients attending a dialysis facility as outpatients who agree to participate in the study
Key exclusion criteria - Patients on peritoneal dialysis
Target Size - 8800
Recruitment Status:
Recruitment status - No longer recruiting
Date of protocol fixation - 2018 Year 03 Month 26 Day
Date of IRB - 2018 Year 03 Month 26 Day
Anticipated trial start date - 2018 Year 04 Month 01 Day
Last follow-up date - 2024 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069077
Disclaimer: Curated by HT Syndication.
